Highlights of ASH in the Mediterranean, Middle East, and North Africa

Join the world's leading hematology experts at Highlights of ASH in the Mediterranean, Middle East, and North Africa, a two-day program that discusses the most influential research presented at the latest ASH annual meeting, the premier event in malignant and classical hematology.
February 13-14, 2026
Istanbul, Türkiye
About Highlights of ASH in the Mediterranean, Middle East, and North Africa
By attending Highlights of ASH, you will get a comprehensive review of significant scientific updates in clinical and translational hematologic research, learn how these updates directly affect the study and practice of hematology, and discover how new research can be translated into cutting-edge patient care.
Through participation in this meeting, you will be able to:
Explore a program that covers the latest and most influential topics in hematology curated from the premier science presented at the ASH annual meeting.
Actively engage in interactive panel discussions with speakers and attend small group lunch sessions with experts in the field.
Connect with a community of individuals who share common goals and hold a mutual appreciation for the scientific advancements.
This meeting has been designed to be a rewarding educational event for hematologists, oncologists, fellows and trainees, allied health professionals, and hematopathologists.
Program Co-Host
ASH is proud to co-host this meeting with the Turkish Society of Hematology.
Program Co-Chairs
The Program Co-Chairs for the Highlights of ASH in the Mediterranean, Middle East, and North Africa are:
- Turkish Society of Hematology Program Co-Chairs
- Dr. Muhlis Cem Ar
- Dr. Sule Cangül Unal
- American Society of Hematology Program Co-Chairs
- Dr. John Molina
- Dr. Rachel P. Rosovsky
Program Schedule
8:00 a.m. - 8:45 a.m. | Registration and Exhibits Open |
8:45 a.m. - 9:00 a.m. | Welcome & Introduction |
9:00 a.m. - 9:30 a.m. | Immune Cytopenias Anem Waheed, MD, MPH Weill Cornell Medicine New York, NY |
9:30 a.m. - 10:15 a.m. |
Hemoglobinopathies & Red Blood Cell Disorders Lydia Pecker, MD John Hopkins Medicine Baltimore, MD Sule Unal Cangül, MD Hacettepe University Ankara, Turkey |
10:15 a.m. - 10:45 a.m. | Panel Discussion |
10:45 a.m. - 11:15 a.m. | Coffee Break in the Exhibit Hall |
11:15 a.m. - 12:30 p.m. | Tumor Board: Acute Myeloid Leukemia Ivana Gojo, MD John Hopkins Medical Center Baltimore, MD Jessica Altman, MD Northwestern Medicine Chicago, IL Maria Teresa Voso, MD University of Rome Rome, Italy John Molina, MD Cleveland Clinic Cleveland, OH |
12:30 p.m. - 1:30 p.m. | Lunch in the Exhibit Hall |
1:30 p.m. - 2:00 p.m. | Transplant Robert Negrin, MD Stanford University Stanford, California |
2:00 p.m. - 2:30 p.m. | Plasma Cell Disorders and Myeloma Rahul Banerjee, MD, FACP Fred Hutchinson Cancer Center Seattle, WA |
2:30 p.m. - 3:00 p.m. | Panel Discussion |
3:00 p.m. - 3:30 p.m. | Coffee Break in the Exhibit Hall |
3:30 p.m. - 4:00 p.m. | Bleeding Disorders Guy Young, MD University of Southern California Los Angeles, CA |
4:00 p.m. - 4:45 p.m. | Women's Health Beverly Hunt, MD Guy's and St. Thomas' NHS Foundation Trust London Ali Taher MD, PhD, FRCP American University of Beirut Beirut, Lebanon |
4:45 p.m. - 5:15 p.m. | Panel Discussion |
5:15 p.m. | Highlights of ASH® Day 1 Program Adjournment |
8:45 a.m. - 9:00 a.m. | Welcome & Introduction |
9:00 a.m. - 9:30 a.m. | Aggressive Lymphoma Paolo Caimi, MD Cleveland Clinic Cleveland, OH |
9:30 a.m. - 10:00 a.m. | Indolent Lymphoma and Chronic Lymphocytic Leukemia Tanya Siddiqi, MD City of Hope Irvine, CA |
10:00 a.m. - 10:30 a.m. | Panel Discussion |
10:30 a.m. - 11:00 a.m. | Coffee Break in the Exhibit Hall |
11:00 a.m. - 12:15 p.m. | Case-Based Presentation: Thrombosis Rachel Rosovsky, MD, MPH Massachusetts General Hospital Boston, Massachusetts Scott C. Woller, MD University of Utah Salt Lake City, UT Reyhan Diz-Kucukkaya, MD Istanbul Bilim University Istanbul, Turkey |
12:15 p.m. - 1:30 p.m. | Lunch in the Exhibit Hall (All Attendees) |
Luch with the Experts (Ticketed) | |
1:30 p.m. - 2:00 p.m. | Acute Lymphoblastic Leukemia John Molina, MD Cleveland Clinic Cleveland, OH |
2:00 p.m. - 2:30 p.m. | Myelodysplastic Syndromes and Myeloproliferative Neoplasms David Sallman, MD Moffitt Cancer Center Tampa, FL |
2:30 p.m. - 3:00 p.m. | Panel Discussion |
3:00 p.m. - 3:30 p.m. | Coffee Break in the Exhibit Hall |
3:30 p.m. - 4:00 p.m. | Pediatric Hematologic Malignancies Adam Lamble, MD Seattle Children's Hospital Seattle, WA |
4:00 p.m. - 4:30 p.m. | Artificial Intelligence and Informatics in Hematology Practice Improvement Amar Kelkar, MD Dana-Farber Cancer Institute Boston, MA |
4:30 p.m. - 5:00 p.m. | Panel Discussion |
5:00 p.m. | Highlights of ASH in the Mediterranean, Middle East, and North Africa Adjournment |